Home>>Infectious Disease>> Bacterial Diseases>> Tuberculosis>>Aranciamycin A

Aranciamycin A Sale

目录号 : GC48472

An antibiotic

Aranciamycin A Chemical Structure

Cas No.:960622-70-2

规格 价格 库存 购买数量
500µg
¥3,751.00
现货
2.5mg
¥13,140.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

Aranciamycin A is an anthracyclic antibiotic that has been found in Streptomyces.1 It is active against M. bovis and B. subtilis (MICs = 30 and 7.5 µM, respectively) but not S. aureus, E. coli, P. aeruginosa, or C. albicans (MICs = >30 µM for all).

1.Khalil, Z.G., Raju, R., Piggott, A.M., et al.Aranciamycins I and J, antimycobacterial anthracyclines from an Australian marine-derived Streptomyces spJ. Nat. Prod.78(4)949-952(2015)

Chemical Properties

Cas No. 960622-70-2 SDF
Canonical SMILES OC1=C(C(C2=C(O)C=CC=C2C3=O)=O)C3=CC(C[C@@](O)(C4)C)=C1[C@H]4O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)O)O)OC
分子式 C26H28O10 分子量 500.5
溶解度 储存条件 -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 1.998 mL 9.99 mL 19.98 mL
5 mM 0.3996 mL 1.998 mL 3.996 mL
10 mM 0.1998 mL 0.999 mL 1.998 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

Research Update

Aranciamycins I and J, Antimycobacterial Anthracyclines from an Australian Marine-Derived Streptomyces sp

J Nat Prod 2015 Apr 24;78(4):949-52.PMID:25789410DOI:10.1021/acs.jnatprod.5b00095.

Chemical analysis of an Australian marine-derived Streptomyces sp. (CMB-M0150) yielded two new anthracycline antibiotics, aranciamycins I (1) and J (2), as well as the previously reported Aranciamycin A (3) and aranciamycin (4). The aranciamycins 1-4, identified by detailed spectroscopic analysis, were noncytotoxic when tested against selected Gram-negative bacteria and fungi (IC50 >30 μM) and exhibited moderate and selective cytotoxicity against Gram-positive bacteria (IC50 >1.1 μM) and a panel of human cancer cell lines (IC50 > 7.5 μM). Significantly, 1-4 were cytotoxic (IC50 0.7-1.7 μM) against the Mycobacterium tuberculosis surrogate M. bovis bacille Calmette-Guérin.